1. Stem cell therapies for chronic obstructive pulmonary disease: mesenchymal stem cells as a promising treatment option
- Author
-
Sumei Lai and Zhifeng Guo
- Subjects
Chronic obstructive pulmonary disease ,Embryonic stem cells ,Induced pluripotent stem cells ,Mesenchymal stem cells ,Extracellular vesicles ,Medicine (General) ,R5-920 ,Biochemistry ,QD415-436 - Abstract
Abstract Chronic obstructive pulmonary disease(COPD) is an inflammatory disease characterized by the progressive and irreversible structural and functional damage of lung tissue. Although COPD is a significant global disease burden, the available treatments only ameliorate the symptoms, but cannot reverse lung damage. Researchers in regenerative medicine have examined the use of stem cell transplantation for treatment of COPD and other diseases because these cells have the potential for unlimited self-renewal and the ability to undergo directed differentiation. Stem cells are typically classified as embryonic stem cells, induced pluripotent stem cells, and adult stem cells (which includes mesenchymal stem cells [MSCs]), each with its own advantages and disadvantages regarding applications in regenerative medicine. Although the heterogeneity and susceptibility to senescence of MSCs make them require careful consideration for clinical applications. However, the low tumourigenicity and minimal ethical concerns of MSCs make them appear to be excellent candidates. This review summarizes the characteristics of various stem cell types and describes their therapeutic potential in the treatment of COPD, with a particular emphasis on MSCs. We aim to facilitate subsequent in-depth research and preclinical applications of MSCs by providing a comprehensive overview.
- Published
- 2024
- Full Text
- View/download PDF